Replies to post #310141 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

That didn't bother me one bit as something I and one or two others have pointed out would be the case - you know <= 21 patients on SAS Cat B turning out to now be maybe 10.

[tredenwater2]

Jager I read it as the trials extensions are exhausted, its someone else’s job to track that info. If even one person with documented Alzheimers is doing better after five years that’s remarkable as the placebo would be done after the first year. If ten are still in it then thats ten husbands or wives, 10’s of hundreds of children and grand children, other family members loved ones, friends....its truly a blessing! Im sure the research and learning are leaps and bounds advanced thanks to the first 32!

[Steady_T]

...but patients being on the drug for more than 5 years is very important information.

Not really. They are no longer in the OLE which means the company is no longer collecting data on them. It would be nice to know but not important.

For that number to be important you would have to know how many there are, why each person dropped out. Was it death from other causes, was it increasing AD, was it other health issues. Since these people are no longer in a clinical trial that information is most likely not being collected.